Logo for Protalix BioTherapeutics Inc

Protalix BioTherapeutics Investor Relations Material

Latest events

Logo for Protalix BioTherapeutics Inc

Q3 2024

Protalix BioTherapeutics
Logo for Protalix BioTherapeutics

Q3 2024

14 Nov, 2024
Logo for Protalix BioTherapeutics

Q2 2024

14 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Protalix BioTherapeutics Inc

Access all reports
Protalix BioTherapeutics Inc. is a biopharmaceutical company focusing on the development, production, and commercialization of recombinant therapeutic proteins using its proprietary ProCellEx plant cell-based protein expression system. This technology enables the company to produce proteins with clinically improved profiles and to develop a pipeline of proprietary therapeutic proteins aimed at established pharmaceutical markets. Additionally, the company is developing other products, including treatments for cystic fibrosis and Fabry Disease, utilizing its platform to manufacture complex proteins, antibodies, and vaccines. The company is headquartered in Carmiel, Israel, and its shares are listed on the NYSE.